Michael Cilento
@drcilento.bsky.social
220 followers
190 following
13 posts
I am a medical oncologist & PhD candidate. Passionate about precision oncology and prostate cancer. Research at SAiGENCI / SAHMRI, UofA.
Posts
Media
Videos
Starter Packs
Michael Cilento
@drcilento.bsky.social
· Feb 13
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicen...
The addition of [177Lu] Lu-PSMA-617 to enzalutamide was associated with improved survival
and some aspects of HRQOL in patients with high-risk metastatic castration-resistant
prostate cancer. Our find...
www.thelancet.com
Michael Cilento
@drcilento.bsky.social
· Jan 30
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial
In the phase 3 IPATential150 trial, ipatasertib addition to abiraterone significantly reduced the risk of disease progression in men with metastatic c…
www.sciencedirect.com
Reposted by Michael Cilento
Kat Morel
@katmorel.bsky.social
· Jan 16
Michael Cilento
@drcilento.bsky.social
· Nov 24
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer - Nature Communications
The prostate cancer tumour microenvironment in the context of treatment remains to be explored. Here, single-cell RNA-sequencing and spatial transcriptomics analysis of samples at multiple treatment p...
doi.org
Michael Cilento
@drcilento.bsky.social
· Nov 24
Spatial transcriptomics in cancer research and potential clinical impact: a narrative review - Journal of Cancer Research and Clinical Oncology
Spatial transcriptomics (ST) provides novel insights into the tumor microenvironment (TME). ST allows the quantification and illustration of gene expression profiles in the spatial context of tissues,...
doi.org
Reposted by Michael Cilento
Ravi Madan
@ravimadan.bsky.social
· Nov 16
Reposted by Michael Cilento
Reposted by Michael Cilento
Michael Cilento
@drcilento.bsky.social
· Nov 20
Michael Cilento
@drcilento.bsky.social
· Nov 20
Michael Cilento
@drcilento.bsky.social
· Nov 20
Michael Cilento
@drcilento.bsky.social
· Nov 20
Michael Cilento
@drcilento.bsky.social
· Nov 20
Michael Cilento
@drcilento.bsky.social
· Nov 20